The Food and Drug Administration (FDA) has now issued a warning about not using sibutramine (Meridia) in patients with a history of cardiovascular disease.
Meridia (sibutramine hydrochloride): Follow-Up to an Early Communication about an Ongoing Safety Review
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment